Recent studies have shown that high levels of C-reactive protein (C-RP), an indicator of systemic inflammation, are associated with increased risk of AMI (as well as metabolic syndrome and type 2 diabetes), independent of the level of CAS (Pradhan et al. 2001; Ridker et al. 2004). This evidence concerns the gene CRP and type 2 diabetes mellitus.